4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Twist Bioscience Corporation (TWST) operates in the Diagnostics & Research industry and is headquartered in South San Francisco, United States with about 979 employees. Its market capitalization is roughly $6 billion. In the fiscal year ended 2025-09-30, TWST reported $377M in revenue and ($78M) in net income.
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products.
Interactive charts & full statements → Open the TWST valuation workbench →
| Income statement | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Revenue | $377M | $313M | $245M | $204M | — |
| Gross Profit | $191M | $133M | $90M | $84M | — |
| Operating Income (EBIT) | ($136M) | ($176M) | ($207M) | ($249M) | — |
| Net Income | ($78M) | ($209M) | ($205M) | ($218M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $111M | $104M | $99M | $96M | $93M | — |
| Gross Profit | $57M | $54M | $51M | $51M | $46M | — |
| Operating Income (EBIT) | ($39M) | ($33M) | ($30M) | ($30M) | ($42M) | — |
| Net Income | ($44M) | ($30M) | ($27M) | $20M | ($39M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Assets | $642M | $614M | $776M | $961M | — |
| Total Liabilities | $169M | $142M | $153M | $172M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TWST viewer.
About TickerBase · Data methodology & sources